Peter C. Brandt, Director at REXAHN PHARMACEUTICALS, INC. (RNN), bought 25,000 shares at $0.95 ($24K) on 2011-09-06, disclosed to the SEC on 2011-09-08.
Open-market purchase of $24k RNN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.94 | 300 | $282 | 1.2% |
| 2 | $0.95 | 300 | $285 | 1.2% |
| 3 | $0.95 | 2,450 | $2K | 9.6% |
| 4 | $0.95 | 3,250 | $3K | 12.8% |
| 5 | $0.95 | 3,900 | $4K | 15.3% |
| 6 | $0.95 | 4,500 |
| $4K |
| 17.7% |
| 7 | $0.95 | 5,300 | $5K | 20.8% |
| 8 | $1.04 | 5,000 | $5K | 21.5% |
| Total | $0.97 avg | 25,000 | $24K | 100% |
| Filing → |
| RNN | BUY | 2011-09-12 | $147K | — | Filing → |
| EPOC | BUY | 2011-09-09 | $142K | — | Filing → |
| EPOC | BUY | 2011-09-08 | $100K | — | Filing → |